Regulation of capillary tubules and lipid formation in vascular endothelial cells and macrophages via extracellular vesicle-mediated microRNA-4306 transfer.


Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 28 11 2018
medline: 7 6 2019
entrez: 28 11 2018
Statut: ppublish

Résumé

This study aimed to examine regulation of capillary tubules and lipid formation in vascular endothelial cells and macrophages via extracellular vesicle-mediated microRNA (miRNA)-4306 transfer. Whole blood samples (12 mL) were collected from 53 patients, and miR-4306 levels in extracellular vesicles (EVs) were analyzed by reverse transcription-polymerase chain reaction. Human coronary artery vascular endothelial cells (HCAECs) and human monocyte-derived macrophages (HMDMs) were transfected with a scrambled oligonucleotide, an miR-4306 mimic, or an anti-miR-4306 inhibitor. The direct effect of miR-4306 on the target gene was analyzed by a dual-luciferase reporter assay. EV-contained miR-4306 released from HMDMs was significantly upregulated in coronary artery disease. Oxidized low-density lipoprotein (ox-LDL)-stimulated HMDM-derived EVs inhibited proliferation, migration, and angiogenesis abilities of HCAECs in vitro. However, ox-LDL-stimulated HCAEC-derived EVs enhanced lipid formation of HMDMs. The possible mechanism of these findings was partly due to EV-mediated miR-4306 upregulation of the Akt/nuclear factor kappa B signaling pathway. Paracrine cellular crosstalk between HCAECs and HMDMs probably supports the pro-atherosclerotic effects of EVs under ox-LDL stress.

Identifiants

pubmed: 30477383
doi: 10.1177/0300060518809255
pmc: PMC6384455
doi:

Substances chimiques

Antagomirs 0
Lipoproteins, LDL 0
MIRN4306 microRNA, human 0
MicroRNAs 0
NF-kappa B 0
Oligoribonucleotides 0
oxidized low density lipoprotein 0
Luciferases EC 1.13.12.-
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-469

Références

Clin Appl Thromb Hemost. 2004 Apr;10(2):133-41
pubmed: 15094933
J Am Coll Cardiol. 2005 May 17;45(10):1622-30
pubmed: 15893178
Eur Heart J. 2006 Apr;27(7):817-23
pubmed: 16434416
PLoS One. 2008;3(11):e3694
pubmed: 19002258
Circ Res. 2010 Oct 29;107(9):1047-57
pubmed: 21030722
Cardiovasc Res. 2012 Mar 15;93(4):633-44
pubmed: 22258631
J Immunol. 2012 Nov 1;189(9):4621-9
pubmed: 23018455
Cardiovasc Res. 2013 Apr 1;98(1):94-106
pubmed: 23341580
Am J Pathol. 2013 May;182(5):1552-62
pubmed: 23499464
J Cardiovasc Transl Res. 2013 Aug;6(4):558-69
pubmed: 23661177
Circ Res. 2013 Jun 21;113(1):7-8
pubmed: 23788500
Chem Soc Rev. 2014 Jan 21;43(2):506-17
pubmed: 24161958
J Immunol. 2014 Jan 1;192(1):437-46
pubmed: 24307738
Eur Heart J. 2014 Nov 7;35(42):2972-9
pubmed: 24742886
J Immunol. 2014 Sep 1;193(5):2483-95
pubmed: 25038257
J Extracell Vesicles. 2014 Sep 08;3:null
pubmed: 25279113
Nanomedicine. 2015 May;11(4):879-83
pubmed: 25659648
Curr Opin Cell Biol. 2015 Aug;35:69-77
pubmed: 26001269
EBioMedicine. 2016 Jan 20;4:86-94
pubmed: 26981573
Eur Heart J. 2017 Feb 14;38(7):516-523
pubmed: 27357355
Annu Rev Physiol. 2017 Feb 10;79:43-66
pubmed: 27992732
Nat Rev Cardiol. 2017 May;14(5):259-272
pubmed: 28150804
Sci Rep. 2017 Aug 15;7(1):8180
pubmed: 28811546
Ann Intern Med. 2017 Sep 19;167(6):394-409
pubmed: 28869986

Auteurs

Ying Yang (Y)

1 Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China; Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Hui Luo (H)

2 Department of Cardiothoracic Surgery, Nanchong Central Hospital, Nanchong, China.

Can Zhou (C)

1 Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China; Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Rongyi Zhang (R)

3 Department of Cardiology, Nanchong Central Hospital, Nanchong, China.

Si Liu (S)

3 Department of Cardiology, Nanchong Central Hospital, Nanchong, China.

Xiao Zhu (X)

1 Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China; Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Sha Ke (S)

1 Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China; Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Hui Liu (H)

1 Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China; Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Zhan Lu (Z)

1 Department of Clinical Medicine, North Sichuan Medical College, Nanchong, China; Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Mao Chen (M)

4 Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH